alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Case 1:02-cr-00451-PKC Document 285 Filed 06/28/22 Page 1 of 2
Case 1:02-cr-00451-PKC Document 285 Filed 06/28/22 Page 2 of 2
#### STATE v. ROTENBERRY

No. 41 P 82.

Case below: 54 N.C. App. 504.

Petition by defendant for writ of certiorari to North Carolina Court of Appeals denied 3 March 1982.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Veterans Affairs

# AGENCY:

Office of Research and Development, VA.

# ACTION:

Notice of Government owned invention available for licensing. 

# SUMMARY:

The invention listed below is owned by the U.S. Government as represented by the Department of Veterans Affairs, and is available for licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or Cooperative Research and Development Agreements (CRADA) Collaboration under 15 U.S.C. 3710a to achieve expeditious commercialization of results of federally funded research and development. Foreign patents are filed on selected inventions to extend market coverage for U.S. companies and may also be available for licensing.

# FOR FURTHER INFORMATION CONTACT:

                        Technical and licensing information on the invention may be obtained by writing to: Amy E. Centanni, Department of Veterans Affairs, Director, Technology Transfer Program, Office of Research and Development, 810 Vermont Avenue, NW., Washington, DC 20420; fax: 202-254-0255; e-mail at:                         *amy.centanni@mail.va.gov.*                         Any request for information should include the Number and Title for the relevant invention as indicated below. Issued patents may be obtained from the Commissioner of Patents, U.S. Patent and Trademark Office, Washington, DC 20231.                    

# SUPPLEMENTARY INFORMATION:

The invention available for licensing is: U.S. Patent Application No. 11/113,786 “Quantitation of Endothelial Microparticles.”

Dated: November 18, 2005.

Gordon H. Mansfield,

Deputy Secretary of Veterans Affairs.

[FR Doc. 05-23299  Filed 11-25-05; 8:45 am]

BILLING CODE 8320-01-M
Case 1:07-cv-03363-GBD     Document 16-6      Filed 06/01/2007     Page 1 of 6

Case 1:07-cv-03363-GBD     Document 16-6      Filed 06/01/2007     Page 2 of 6

Case 1:07-cv-03363-GBD     Document 16-6      Filed 06/01/2007     Page 3 of 6

Case 1:07-cv-03363-GBD     Document 16-6      Filed 06/01/2007     Page 4 of 6

Case 1:07-cv-03363-GBD     Document 16-6      Filed 06/01/2007     Page 5 of 6

Case 1:07-cv-03363-GBD     Document 16-6      Filed 06/01/2007     Page 6 of 6
#### ELECTRIC CO. v. NEWSPAPERS, INC.

No. 73 PC.

Case below: 22 N.C. App. 519.

Petition for. writ of certiorari to North Carolina Court of Appeals denied 24 September 1974.
[Federal Register Volume 70, Number 224 (Tuesday, November 22, 2005)]
[Notices]
[Page 70617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23103]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration on Aging


2005 White House Conference on Aging

AGENCY: Administration on Aging, HHS.

ACTION: Notice of conference call.

-----------------------------------------------------------------------

SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee 
Act as amended (5 U.S.C. Appendix 2), notice is hereby given that the 
Policy Committee of the 2005 White House Conference on Aging (WHCoA) 
will have a conference call to finalize the resolutions and other items 
related to the 2005 WHCoA. The conference call will be open to the 
public to listen, with call-ins limited to the number of telephone 
lines available. Individuals who plan to call in and need special 
assistance, such as TTY, should inform the contact person listed below 
in advance of the conference call. This notice is being published less 
than 15 days prior to the conference call due to scheduling problems.

DATES: The conference call will be held on Tuesday, November 22, 2005, 
at 4:30 p.m., eastern standard time.

ADDRESSES: The conference call may be accessed by dialing, U.S. toll-
free,
1-800-857-0419, passcode: 8932323, on the date and time indicated 
above.

FOR FURTHER INFORMATION CONTACT: Kim Butcher, (301) 443-2887, or e-mail 
at <a href="/cdn-cgi/l/email-protection#73381a1e5d310607101b160133041b101c125d141c05"><span class="__cf_email__" data-cfemail="b1fad8dc9ff3c4c5d2d9d4c3f1c6d9d2ded09fd6dec7">[email protected]</span></a>. Registration is not required. Call in is on a 
first come, first-served basis.

SUPPLEMENTARY INFORMATION: Pursuant to the Older Americans Act 
Amendments of 2000 (Pub. L. 106-501, November 2000), the Policy 
Committee will have a meeting by conference call to finalize on the 
resolutions that will be mailed to the delegates for review prior to 
the WHCoA that is scheduled from December 11 to 14, 2005. The public is 
invited to listen by dialing the telephone number and using the 
passcode listed above under the Addresses section.

    Dated: November 17, 2005.
Edwin L. Walker,
Deputy Assistant Secretary for Policy and Programs.
[FR Doc. 05-23103 Filed 11-21-05; 8:45 am]
BILLING CODE 4154-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE ENSTAR
GROUP, INC.'S AUDITED FINANCIAL STATEMENTS CONTAINED IN ITS REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          79,390
<SECURITIES>                                     3,695
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                             138
<DEPRECIATION>                                      79
<TOTAL-ASSETS>                                  84,702
<CURRENT-LIABILITIES>                              316
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            57
<OTHER-SE>                                      83,654
<TOTAL-LIABILITY-AND-EQUITY>                    84,702
<SALES>                                              0
<TOTAL-REVENUES>                                 1,280
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                   650
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   3
<INCOME-PRETAX>                                    627
<INCOME-TAX>                                        14
<INCOME-CONTINUING>                                613
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       613
<EPS-BASIC>                                       0.12
<EPS-DILUTED>                                     0.12


</TABLE>
IC 

116TH CONGRESS 

1ST SESSION S. 2035 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 11, 2019 

Referred to the Committee on Homeland Security 

AN ACT 

To require the Transportation Security Administration to 

develop a strategic plan to expand eligibility for the 

PreCheck Program to individuals with Transportation 

Worker Identification Credentials or Hazardous Materials Endorsements. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pamtmann on DSKBC07HB2PROD with BILLS
2 

S 2035 RFH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘TSA Credential and 

3 Endorsement Harmonization Act of 2019’’. 

4 SEC. 2. STRATEGIC PLAN TO EXPAND PRECHECK PRO5 GRAM. 

6 (a) IN GENERAL.—Not later than 180 days after the 

7 date of the enactment of this Act, the Administrator of 

8 the Transportation Security Administration shall develop 

9 a strategic plan to expand eligibility for the PreCheck Pro10 gram under section 44919 of title 49, United States Code, 

11 to individuals who have— 

12 (1) a Transportation Worker Identification Cre13 dential issued under section 70105 of title 46, 

14 United States Code; or 

15 (2) a Hazardous Materials Endorsement under 

16 the Hazardous Materials Endorsement Threat As17 sessment Program on the State-issued commercial 

18 driver’s license of the individual. 

19 (b) ELEMENTS.—In developing the strategic plan re20 quired by subsection (a), the Administrator shall ensure 

21 that the plan— 

22 (1) allows individuals described in subsection 

23 (a) to opt in to the PreCheck Program; and 

24 (2) provides the Transportation Security Ad25 ministration with the discretion— 


pamtmann on DSKBC07HB2PROD with BILLS
3 

S 2035 RFH

1 (A) to determine whether an individual de2 scribed in subsection (a) meets the eligibility re3 quirements for the Program; and 

4 (B) to establish alternative fee structures 

5 for the Program. 

6 (c) BRIEFING TO CONGRESS.—Not later than 30 

7 days after developing the strategic plan required by sub8 section (a), the Administrator shall brief the Committee 

9 on Commerce, Science, and Transportation of the Senate 

10 and the Committee on Homeland Security of the House 

11 of Representatives on the strategic plan. 

Passed the Senate September 10, 2019. 

Attest: JULIE E. ADAMS, 

Secretary. 


pamtmann on DSKBC07HB2PROD with BILLS
<PAGE>

                                                                    EXHIBIT 24.1

                               POWER OF ATTORNEY

   KNOW ALL BY THESE PRESENTS, that each person whose signature appears below
constitutes and appoints each of John J. Davis and Scott P. Halstead, with full
power to each to act without the other, his or her true and lawful attorney-in-
fact and agent with full power of substitution, for him or her and in his or
her name, place and stead, in any and all capacities, to sign the Annual Report
on Form 10-K of eBenX, Inc. (the "Company") for the Company's fiscal year ended
December 31, 1999, and any or all amendments to said Annual Report, and to file
the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, and to file the same
with such other authorities as necessary, granting unto each such attorney-in-
fact and agent full power and authority to do and perform each and every act
and thing requisite and necessary to be done in and about the premises, as
fully to all intents and purposes as he or she might or could do in person,
hereby ratifying and confirming all that each such attorney-in-fact and agent,
or his substitute, may lawfully do or cause to be done by virtue hereof.

   IN WITNESS WHEREOF, this Power of Attorney has been signed on this 27th day
of March, 2000, by the following persons.

<TABLE>
<S>                     <C>
____________/s/ Mark W. Tierney_____      _______/s/ James P. Bradley_______
              Mark W. Tierney                     James P. Bradley

_____________/s/ John J. Davis______      ______/s/ Daniel M. Cain__________
              John J. Davis                        Daniel M. Cain

___________/s/ Scott P. Halstead____      ______/s/ William J. Geary________
             Scott P. Halstead                     William J. Geary

__________/s/ Michael C. Bingham____      ______/s/ John Nehra_______________
             Michael C. Bingham                     John Nehra

____________/s/ Paul V. Barber______
               Paul V. Barber

</TABLE>
#### COLLINS v. INSURANCE CO.

No. 189 PC.

No. 111 (Spring Term).

Case below: 39 N.C. App. 38.

Petition by defendant for discretionary review under G.S. 7A-31 allowed 6 March 1979.
#### TROTTER v. TROTTER

No. 289 PC.

Case below: 52 N.C. App. 586.

Petition by defendant for discretionary review under G.S. 7A-31 denied 6 October 1981.
a4501pgeamendmentletter






  Constellium International  40-44, rue Washington  75008 Paris  France    Tel: +33 (1) 73 01 46 20  www.constellium.com     Constellium International  Société par actions simplifiée au capital de 20.168.666 €  40-44, rue Washington, 75008 Paris  832 509 418 RCS Paris    Joëlle Labrousse  BNP PARIBAS - Agency EMEA – Relationship  Manager  Millénaire 4   35 Rue de la Gare - 75019 Paris   Tel : 0033.1.43.16.92.40  Email : joelle.labrousse@bnpparibas.com        Paris, 30 April 2021      To: BNP Paribas in its capacity as Agent (as defined below)      Dear BNP Paribas team,    Reference is made to a €180,000,000 facility agreement dated 13 May 2020 in respect of a prêt  garanti par l'Etat granted to Constellium International as Company by the Lenders named therein (the  "Agreement").     Unless otherwise specified, defined terms used in this letter have the meaning given to them in the  Agreement.    This letter is designated as a Finance Document.    We, acting in our capacity as Company, hereby request the unanimous consent of the Lenders to  modify the terms of Clause 21.17 (Debt Capital Market Issue) of the Agreement so that, in such  Clause, a reference to the Initial Termination Date (i.e., 20 May 2021) be replaced by a reference to  20 August 2021 and that, accordingly, Clause 21.17 (Debt Capital Market Issue) of the Agreement be  replaced by the following:    “21.17   Debt Capital Market Issue   If Constellium SE makes any Debt Capital Markets Issue after 20 August 2021, Constellium  SE fails to apply (through the Company) the net proceeds of any such issue in priority towards  the voluntary prepayment of the Loan in accordance with the terms of this Agreement.”    Save as specified above no other terms of the Agreement will be modified as a result of this letter.    This letter shall not be construed as effecting any novation of the terms of the Agreement or any other  Finance Document.    This letter is governed by French law and any dispute arising under or in connection with its terms  shall be subject to the exclusive jurisdiction of the Tribunal de commerce de Paris.    We would be most grateful if you could countersign on behalf of all the Lenders and return a  countersigned copy of this letter to us no later than by 14 May 2021 at 5:00 pm CET. Upon your  countersignature, the amendment requested above shall enter into force immediately and  unconditionally.    





 






    Constellium International  Société par actions simplifiée au capital de 20.168.666 €  40-44, rue Washington, 75008 Paris  832 509 418 RCS Paris  2   Sincerely yours,    [SIGNATURE]    ___________________  Constellium International  By: Laurent Schmitt  Title: General Manager (“Directeur Général”)        We, the Agent, acting in the name and on behalf of all the Lenders, agree to the amendment of  Clause 21.17 (Debt Capital Market Issue) of the Agreement set out in this letter.    [SIGNATURES]    ______________  BNP PARIBAS  By:  Title:  12 May 2021
<TABLE> <S> <C>



<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Balance Sheet at September 30, 1998, and the Consolidated Statement
of Income for the period ending September 30, 1998, and is qualified in its
entirety by reference to such Form 10-Q.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                          251200
<SECURITIES>                                         0
<RECEIVABLES>                                   275600
<ALLOWANCES>                                         0
<INVENTORY>                                     234700
<CURRENT-ASSETS>                                798600
<PP&E>                                         4884300
<DEPRECIATION>                                 2325700
<TOTAL-ASSETS>                                 3731400
<CURRENT-LIABILITIES>                           555700
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         54200
<OTHER-SE>                                     1602500
<TOTAL-LIABILITY-AND-EQUITY>                   3731400
<SALES>                                        1045000
<TOTAL-REVENUES>                               1045000
<CGS>                                           594800
<TOTAL-COSTS>                                  1017300
<OTHER-EXPENSES>                                  1900
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               43400
<INCOME-PRETAX>                                  22200
<INCOME-TAX>                                      3100
<INCOME-CONTINUING>                              19100
<DISCONTINUED>                                  277400
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    296500
<EPS-PRIMARY>                                     6.23
<EPS-DILUTED>                                     6.21
        


</TABLE>
UNITED STATES DISTRICT COLRT . . SOUTHERN DISTRICT OF NEW YORK . , 

................................................ ------ x.: ' . . : .. . . -. . / ,<-.;: : 4 -I ... I -. . . . .: 7 taE 

. .' ll7 

, -; . .. , .. . . ' , ,-( .,-. ..>.I - , ., -' ' : . . . , . . . ' _-_I :. ; I 

DOMINIK DIFRISCO AND SUSAN DIFRISCO, ; .......-.--&.. -'- ., , , . . ".-1 .- I '-a ' "' - .- . .*- -?- 

. . , ., . - - _. . ..-. 

Plaintiffs, 07 Civ. 353 1 (CM) (DF) 

ORDER 

MARRIOT INTERNATIONAL, INC., 

Defendant. 

........................................................................ X 

DEBRA FREEMAN, United States Magistrate Judge: 

The Court having received a motion by defendant, dated June 5,2008 (Dkt. 18), seeking 

to hold non-party Aimee Yohann in contempt for failing to appear for a deposition pursuant to 

subpoena; and the Court having requested submission of proof of service of the motion on 

Ms. Yohann; and defendant having now infonned the Court by letter dated July 22, 2008 that, 

"[dlue to an inadvertent mistake by [counsel's] office," Ms. Yohann was not served with the 

motion and thus had no opportunity to respond; and defendant having requested the opportunity 

(a) to serve Ms. Yohann with the motion, and (b) to afford Ms. Yohann 30 days either to appear 

for deposition or to submit a response to the motion; it is hereby ORDERED as follows: 

1. Defendant is directed to serve Ms. Yohann with a copy of defendant's motion, 

plaintiffs' opposition, and defendant's reply, together with a copy of this Order, no later than 

July 25,2008. 

2. Ms. Yohann is directed to contact defendant's counsel immediately upon receipt 

of service, so as to schedule a new date (not later than August 25, 2008) for her deposition. 

Ms. Yohann is further directed to appear to give deposition testimony on the scheduled date, and 

Case 1:07-cv-03531-CM-DCF Document 20 Filed 07/23/2008 Page 1 of 2
she is cautioned that, if she fails to do so, she may be held in contempt of the subpoena 

previously served upon her, as well as this Order, and may be subject to contempt sanctions, 

including but not limited to those requested by defendant's motion. 

3. Defendant's motion is denied without prejudice to renew, if Ms. Yohann fails to 

contact counsel in accordance with this Order, or fails to appear for a rescheduled deposition. 

4. If Ms. Yohann wishes to make any submission to this Court, and if she is not 

represented by counsel, then any submission should be directed to the Court's Pro Se Office, 

Room 230, United States Courthouse, 500 Pearl Street, New York, NY 10007 

Dated: New York, New York 

July 23, 2008 

SO ORDERED 

'-'/' - -7 P* &;I ,,J ?//---- 

DEBRA FREEMAN 

United States Magistrate Judge 

Copies to: 

Hon. Colleen McMahon, U.S.D.J. 

Stephen B. Toner, Esq. 

Russo, Keane & Toner LLP 

26 Broadway 

28th Floor 

New York, NY 10004 

Paul A. Fino, Jr., Esq. 

Daniel MacLaren Stewart, Esq. 

White Fleischner & Fino, LLP 

61 Broadway 

New York, NY 10006 

Case 1:07-cv-03531-CM-DCF Document 20 Filed 07/23/2008 Page 2 of 2
Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Kewaunee Scientific Corporation (the Company) for the
period ended July 31, 2009, I, William A. Shumaker, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
my knowledge:



| | (1) | such Form 10-Q of the Company for the period ended July 31, 2009, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in such Form 10-Q of the Company for the period ended July 31, 2009, fairly presents, in all material respects, the financial condition and results of
operations of the Company.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: September 11, 2009



/s/ William A. ShumakerWilliam A. Shumaker President and Chief Executive
Officer